Abbott Laboratories Sentenced for Misbranding Drug
Abbott Laboratories Sentenced for Misbranding Drug
Pharmaceutical manufacturer Abbott Laboratories Inc. was sentenced by U.S. District Court Judge Samuel G. Wilson of the Western District of Virginia in connection with its guilty plea related to its unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration.